A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of RVT-2401 in MyastheniaGravis Patients

Project: Research project

Project Details

Description

A Phase 2a, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study of RVT-2401 in Myasthenia Gravis Patients
StatusActive
Effective start/end date1/1/1912/31/21

Funding

  • IMMUNOVANT, INC.

Fingerprint

Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.